{ }
001122334455554433221100
001122334455554433221100

ubs group initiates coverage on tyra biosciences with buy rating and price target

Ally Bridge Group NY LLC and Ensign Peak Advisors Inc. made significant new investments in Tyra Biosciences, with stakes worth approximately $4.23 million and $3.05 million, respectively. American Century Companies Inc. increased its stake by 582.9%, now holding 170,283 shares valued at $2.72 million. The company, focused on precision medicines for FGFR biology, has a consensus "Buy" rating from analysts, with a target price averaging $30.50, despite recent earnings missing expectations.

Machinary offers a groundbreaking, modular, and customizable solution that provides advanced financial news and statistical analysis. Our platform goes beyond traditional quantitative analysis, offering users a comprehensive understanding of real-time market dynamics, event detection, and risk analysis.

Address

Newsletter

© 2025 by Machinary.com - Version: 1.0.0.0. All rights reserved

Layout

Color mode

Theme mode

Layout settings

Seems like the connection with the server has been lost. It can be due to poor or broken network. Please hang on while we're trying to reconnect...
Oh snap! Failed to reconnect with the server. This is typically caused by a longer network outage, or if the server has been taken down. You can try to reconnect, but if that does not work, you need to reload the page.
Oh man! The server rejected the attempt to reconnect. The only option now is to reload the page, but be prepared that it won't work, since this is typically caused by a failure on the server.